Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Sendai virus-based production of HIV type 1 subtype B and subtype E envelope glycoprotein 120 antigens and their use for highly sensitive detection of subtype-specific serum antibodies
Authors: Hidenobu Toriyoshi
Tatsuo Shioda
Hironori Sato
Masahiro Sakaguchi
Yasuyuki Eda
Sachio Tokiyoshi
Kayoko Kato
Kyoko Nohtomi
Shigeru Kusagawa
Kiyomi Taniguchi
Teiichiro Shiino
Atsushi Kato
Suporn Foongladda
Sirirat Linkanonsakul
Shin Ichi Oka
Aikichi Iwamoto
Chantapong Wasi
Yoshiyuki Nagai
Yutaka Takebe
National Institute of Infectious Diseases
Institute of Medical Science The University of Tokyo
Chemo-Sero-Therapeut. Res. Institute
Mahidol University
Bamrasnaradura Infectious Disease Institute
National Center for Global Health and Medicine
Keywords: Immunology and Microbiology;Medicine
Issue Date: 10-Aug-1999
Citation: AIDS Research and Human Retroviruses. Vol.15, No.12 (1999), 1109-1120
Abstract: We previously described a Sendai virus (SeV)-based expression system for the recombinant gp120 of HIV-1 subtype B (rgp120-B), which has permitted the production of antigenetically and functionally authentic gp120 at a concentration as high as 6 μg/ml of culture supernatant (Yu D et al.: Genes Cells 1997;2:457-466). Here the same procedure was successfully applied to the production of HIV-1 subtype E gp120 (rgp120-E). The remarkable production of the proteins by the SeV expression system enabled us to use crude culture supernatants for serological and functional studies of gp120s. The immunological authenticity of rgp120-E was verified by patient sera and anti- V3 loop monoclonal antibodies specific for HIV-1 subtypes B and E. CD4- binding properties were corroborated by FACS analyses. The rgp120s were then used in an enzyme immunoassay (rgp120-EIA) to detect antibodies in the sera of HIV-1-infected individuals, and the performance was assessed in comparison with a conventional V3 loop peptide EIA (V3-EIA). The initial evaluation of a serum panel (n = 164) consisting of 76 subtype E and 88 subtype B sera revealed that the rgp120-EIA was nearly 1000-fold more sensitive than the V3- EIA and was able to detect subtype-specific antibody with 100% sensitivity and with a complete correlation with the genotypes, whereas the V3-EIA failed to detect 9 and 24% of the same subtype E and B sera, respectively. Furthermore, a study employing a panel of 28 international sera with known genotypes (HIV-1 subtypes A through F) confirmed the remarkable specificity of this method. An EIA reactivity higher than 1.0 was an unambiguous predictor of HIV-1 subtype E and B infections. The data imply the presence of strong subtype-specific epitopes for antibody bindings to these rgp120s.
ISSN: 08892229
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.